期刊文献+

PD-1:PD-L1/PD-L2通路在结核感染中的免疫作用 被引量:2

The immune role of PD-1: PD-L1 / PD-L2 pathway in Mycobacterium tuberculosis infection
下载PDF
导出
摘要 PD-1:PD-L1/PD-L2通路在肿瘤和某些感染性疾病中发挥免疫抑制作用,而在结核病中的免疫作用尚不明确。结核菌感染后,免疫细胞上PD-1:PD-L1/PD-L2通路高表达,体外实验显示:用该通路的抗体阻断后保护性T细胞增强,而体内免疫作用不明确。PD-1与配体PD-L1结合后可能发挥免疫抑制作用,其中PD-L1表达受Th1细胞因子调控;PD-1与配体PD-L2结合后可能发挥免疫保护作用,其中PD-L2表达受Th2型细胞因子调控。利用Cas9-CRISPR基因敲除方法分别敲除特定免疫细胞上PD-1、PD-L1和PD-L2,可研究PD-1、PD-L1和PD-L2在结核感染中免疫作用及机制,为结核病的防控提供理论依据。 PD-1:PD-L1/PD-L2 pathway played negative immune role in most tumor and several infectious diseases, but the immune role in tuberculosis ( TB) was not explicited.Since the high expression of PD-1:PD-L1/PD-L2 pathway was correlated with MTB infection both in vitro and in vivo, the in vitro negative immune role was indicated by inhibited T cell protective immune function, while the in vivo immune role was not clear.The binding of PD-1 and PD-L1 played an immunosuppression role, the expression of PD-L1 was regulated by Th1-type cytokines.The binding of PD-1 and PD-L2 played protective immune role, and the expression was regulated by Th1-type cytokines.The immune role and mechanism of PD-1, PD-L1 and PD-L2 would be investigated by Cas9-CRISPR technique, which would provide theoretical basis for the tuberculosis prevention and control.
出处 《中国比较医学杂志》 北大核心 2015年第7期74-76,共3页 Chinese Journal of Comparative Medicine
基金 “十二五-艾滋病和病毒性肝炎等重大传染病防治”国家科技重大专项子课题(2012ZX10004501)
关键词 PD-1: PD-L1 /PD-L2 通路 结核感染 免疫作用 PD-1:PD-L1/PD-L2 pathway Mycobacterium tuberculosis infection Immune role
  • 相关文献

参考文献22

  • 1Tubo NJ, Jenkins MK. CD4 + T Cells; Guardians of thePhagosome. Clinical Microbiology Reviews 2014, 27 (2):200-213.
  • 2Flynn JL, Chan J. Immunology of tuberculosis. Annual review ofimmunology 2001 , 19( 1 ) :93 ~ 129.
  • 3Urdahl KB, Shafiani S,Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunology 2011 , 4(3):288 -293.
  • 4Hamid 0, Carvajal RD. Anti-programmed death - 1 and anti-programmed death-ligand 1 antibodies in cancer therapy. ExpertOpin Biol Ther 2013, 13(6):847 -861.
  • 5Sakthivel P, Gereke M , Bruder D. Therapeutic Intervention inCancer and Chronic Viral Infections : Antibody MediatedManipulation of PD - 1/PD-L1 Interaction. Reviews on RecentClinical Trials 7,2012, 7(1):10 -23.
  • 6Akbari 0,Stock P, Singh AK,et al. PD-L1 and PD-L2modulate airway inflammation and iNKT-cell-dependent airwayhyperreactivity in opposing directions. Mucosal Immunology2009,3(1) :81 -91.
  • 7Loke P,Allison JP. PD-L1 and PD-L2 are differentiallyregulated by Thl and Th2 cells. Proceedings of the NationalAcademy of Sciences 2003 , 100(9) :5336 -5341.
  • 8Javier O. Jurado IBA, Virginia Pasquinelli, et al. ProgrammedDeath (PD) - 1 : PD-Ligand 1/PD-Ligand 2 Pathway Inhibits TCell Effector Functions during Human Tuberculosis. The Journalof Immunology 2008,181(1) :116-125.
  • 9Singh A, Mohan A, Dey AB, et al. Inhibiting the ProgrammedDeath 1 Pathway Rescues Mycobacterium tuberculosis-SpecificInterferon-Producing T Cells From Apoptosis in Patients WithPulmonary Tuberculosis. Journal of Infectious Diseases 2013,208(4) :603 -615.
  • 10Sakai S, Kawamura I, Okazaki T, et al. PD - 1 - PD-LI pathway impairs Thl immune response in the late stage of infection with Mycobacterium boris bacillus Calmette-Guerin. International Immunology 2010, 22 (12) :915 - 925.

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部